Stay updated on Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page.

Latest updates to the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedDocument revision updated from v3.4.1 to v3.4.2; no user-facing content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed; this is a backend version note and does not affect the study information displayed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedThe page footer now includes a Show glossary option and a new 'Last Update Submitted that Met QC Criteria' line with revision 'v3.4.0'. The older 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' text have been removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision changed from v3.3.3 to v3.3.4. This appears to be a minor administrative update to the study record.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a Locations section with New Jersey as a study site (New Brunswick, New Jersey).SummaryDifference0.2%

- Check92 days agoChange DetectedPubMed publications section wording updated to indicate that publications are auto-filled from PubMed, replacing the previous description. The revision tag was updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Trigriluzole With Immunotherapy in Solid Tumors Clinical Trial page.